AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Rubino, T Vigano, D Massi, P Parolaro, D
Citation: T. Rubino et al., The psychoactive ingredient of marijuana induces behavioural sensitization, EUR J NEURO, 14(5), 2001, pp. 884-886

Authors: Massi, P Vaccani, A Romorini, S Parolaro, D
Citation: P. Massi et al., Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects, J NEUROIMM, 117(1-2), 2001, pp. 116-124

Authors: Ponti, W Rubino, T Bardotti, M Poli, G Parolaro, D
Citation: W. Ponti et al., Cannabinoids inhibit nitric oxide production in bone marrow derived felinemacrophages, VET IMMUNOL, 82(3-4), 2001, pp. 203-214

Authors: Braida, D Pozzi, M Parolaro, D Sala, M
Citation: D. Braida et al., Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system, EUR J PHARM, 413(2-3), 2001, pp. 227-234

Authors: Rubino, T Vigano, D Zagato, E Sala, M Parolaro, D
Citation: T. Rubino et al., In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: Behavioral and cellular responses after acute and chronic treatments, SYNAPSE, 35(1), 2000, pp. 8-14

Authors: Sacerdote, P Massi, P Panerai, AE Parolaro, D
Citation: P. Sacerdote et al., In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors, J NEUROIMM, 109(2), 2000, pp. 155-163

Authors: Rubino, T Vigano, D Massi, P Spinello, M Zagato, E Giagnoni, G Parolaro, D
Citation: T. Rubino et al., Chronic Delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions, NEUROPHARM, 39(7), 2000, pp. 1331-1336

Authors: Rubino, T Massi, P Vigano, D Fuzio, D Parolaro, D
Citation: T. Rubino et al., Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome, LIFE SCI, 66(22), 2000, pp. 2213-2219

Authors: Rubino, T Vigano, D Costa, B Colleoni, M Parolaro, D
Citation: T. Rubino et al., Loss of cannabinoid-stimulated guanosine 5 '-O-(3-[S-35]thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats, J NEUROCHEM, 75(6), 2000, pp. 2478-2484

Authors: Rubino, T Vigano, D Massi, P Parolaro, D
Citation: T. Rubino et al., Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the syntheticcannabinoid compound CP55,940, J NEUROCHEM, 75(5), 2000, pp. 2080-2086

Authors: Massi, P Fuzio, D Vigano, D Sacerdote, P Parolaro, D
Citation: P. Massi et al., Relative involvement of cannabinoid CB1 and CB2 receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activity, EUR J PHARM, 387(3), 2000, pp. 343-347

Authors: Bianchi, M Maggi, R Pimpinelli, F Rubino, T Parolaro, D Poli, V Ciliberto, G Panerai, AE Sacerdote, P
Citation: M. Bianchi et al., Presence of a reduced opioid response in interleukin-6 knock out mice, EUR J NEURO, 11(5), 1999, pp. 1501-1507

Authors: Parolaro, D
Citation: D. Parolaro, Presence and functional regulation of cannabinoid receptors in immune cells, LIFE SCI, 65(6-7), 1999, pp. 637-644

Authors: Basilico, L Parolaro, D Colleoni, M Costa, B Giagnoni, G
Citation: L. Basilico et al., Cross-tolerance and convergent dependence between morphine and cannabimimetic agent WIN 55,212-2 in the guinea-pig ileum myenteric plexus, EUR J PHARM, 376(3), 1999, pp. 265-271

Authors: Massi, P Sacerdote, P Ponti, W Fuzio, D Manfredi, B Vigano, D Rubino, T Bardotti, M Parolaro, D
Citation: P. Massi et al., Immune function alterations in mice tolerant to Delta(9)-tetrahydrocannabinol: functional and biochemical parameters, J NEUROIMM, 92(1-2), 1998, pp. 60-66
Risultati: 1-15 |